Huntington Times

The West Virginia Collegiate Recovery Network (WVCRN), operating under the Marshall University Research Corporation, has partnered with CHESS Health to launch a digital initiative aimed at reducing hepatitis C (HCV) cases in West Virginia. The state's HCV rate is notably higher than the national average.

Hepatitis C is a liver inflammation caused by viral infections that can lead to severe health issues like cirrhosis, liver failure, and cancer. Despite being treatable, many individuals face barriers such as stigma and financial concerns that prevent them from seeking care. Teresa Warner, director of the program, highlighted these challenges: "Myths about HCV, along with concerns about treatment costs, can hinder access, particularly among high-risk groups."

The Live(r) Hep C Free program employs CHESS Health’s Rewards Engine to encourage testing and treatment through incentives. Participants receive $25 for completing an HCV test and another $25 upon finishing necessary treatment. Peer navigators with personal experience also assist participants throughout the process.

Warner emphasized early intervention: “We’re trying to reach people in the early stages before the disease causes liver damage or side effects. We want to educate people about the treatment so they understand there is hope and a cure.”

CHESS Health CEO Hans Morefield expressed optimism about the partnership's potential impact: “We are pleased to partner with the Live(r) Hep C Free program to help them achieve their goals of reducing the harmful impact of HCV in their communities.” He added that this initiative could provide valuable insights into using contingency management strategies for positive health outcomes.

The program also offers free online training to promote participation in HCV testing and treatment. Interested individuals can find more information or enroll at wvcrn-s-site.thinkific.com/courses/hcv.